Mymetics Corp
Mymetics Corporation engages in the research and development of vaccines for infectious and life disabling diseases in Switzerland. The company's product pipeline includes various vaccine candidates, such as HIV-1/AIDS, Covid-19, intra nasal influenza, respiratory syncytial virus, and malaria. Mymetics Corporation has a collaboration agreement with Texas Biomedical Research Institute; and nationa… Read more
Mymetics Corp (MYMX) - Total Liabilities
Latest total liabilities as of September 2023: $75.67 Million USD
Based on the latest financial reports, Mymetics Corp (MYMX) has total liabilities worth $75.67 Million USD as of September 2023.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Mymetics Corp - Total Liabilities Trend (1998–2022)
This chart illustrates how Mymetics Corp's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Mymetics Corp Competitors by Total Liabilities
The table below lists competitors of Mymetics Corp ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Acheter-Louer.Fr SA
F:2ZT1
|
Germany | €8.72 Million |
|
Tribe Technology PLC
LSE:TRYB
|
UK | GBX6.87 Million |
|
BC Craft Supply Co. Ltd
PINK:CRFTF
|
USA | $10.38 Million |
|
Guyana Gold Corp
PINK:GYGC
|
USA | $291.14K |
|
HYBRIGENICS A-
BE:3HB
|
Germany | €5.72 Million |
Liability Composition Analysis (1998–2022)
This chart breaks down Mymetics Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.00 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.00 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 756.70 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Mymetics Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Mymetics Corp (1998–2022)
The table below shows the annual total liabilities of Mymetics Corp from 1998 to 2022.
| Year | Total Liabilities | Change |
|---|---|---|
| 2022-12-31 | $72.22 Million | +6.64% |
| 2021-12-31 | $67.72 Million | +6.73% |
| 2020-12-31 | $63.45 Million | +7.76% |
| 2019-12-31 | $58.88 Million | +7.38% |
| 2018-12-31 | $54.83 Million | +7.68% |
| 2017-12-31 | $50.92 Million | +8.07% |
| 2016-12-31 | $47.12 Million | +5.65% |
| 2015-12-31 | $44.60 Million | +8.52% |
| 2014-12-31 | $41.10 Million | +2.19% |
| 2013-12-31 | $40.22 Million | -5.55% |
| 2012-12-31 | $42.58 Million | +12.58% |
| 2011-12-31 | $37.82 Million | +9.07% |
| 2010-12-31 | $34.68 Million | +3.29% |
| 2009-12-31 | $33.57 Million | +236.09% |
| 2008-12-31 | $9.99 Million | +265.75% |
| 2007-12-31 | $2.73 Million | -35.76% |
| 2006-12-31 | $4.25 Million | +2.64% |
| 2005-12-31 | $4.14 Million | +21.91% |
| 2004-12-31 | $3.40 Million | -28.60% |
| 2003-12-31 | $4.76 Million | +68.24% |
| 2002-12-31 | $2.83 Million | +182.76% |
| 2001-12-31 | $1.00 Million | +778.00% |
| 2000-12-31 | $113.93K | +279.76% |
| 1999-12-31 | $30.00K | -96.91% |
| 1998-12-31 | $970.00K | -- |